Abstract

Influenza vaccination is an effective public health measure to reduce the risk of influenza illness, particularly when the vaccine is well matched to circulating strains. Notwithstanding, the efficacy of influenza vaccination varies greatly among vaccinees due to largely unknown immunological determinants, thereby dampening population-wide protection. Here, we report that dietary fibre may play a significant role in humoral vaccine responses. We found dietary fibre intake and the abundance of fibre-fermenting intestinal bacteria to be positively correlated with humoral influenza vaccine-specific immune responses in human vaccinees, albeit without reaching statistical significance. Importantly, this correlation was largely driven by first-time vaccinees; prior influenza vaccination negatively correlated with vaccine immunogenicity. In support of these observations, dietary fibre consumption significantly enhanced humoral influenza vaccine responses in mice, where the effect was mechanistically linked to short-chain fatty acids, the bacterial fermentation product of dietary fibre. Overall, these findings may bear significant importance for emerging infectious agents, such as COVID-19, and associated de novo vaccinations.

Highlights

  • Vaccination is our best defence against severe illness and death caused by influenza viruses

  • After conducting ad hoc analyses to assess the impact of dietary fibre intake on TIVspecific humoral immune responses, we identify a correlation between fibre consumption and vaccine responses in individuals who are naïve to previous influenza vaccination

  • These findings reveal an unappreciated role for a diet rich in fibre in inducing a robust antibody response to seasonal influenza vaccine

Read more

Summary

Introduction

Vaccination is our best defence against severe illness and death caused by influenza viruses. Immune responses to seasonal influenza vaccinations vary substantially in efficacy across the general population, leaving some individuals susceptible to infection each season, even after being vaccinated. The reason for this variation is mostly unknown. Compelling animal studies have shown that a disrupted microbiome will impair vaccine-induced antibody responses [3,4,5,6]. Despite this growing body of work, our understanding of whether the microbiome impacts these same immunological processes in humans is surprisingly under-studied. A limited number of clinical studies demonstrate correlations between microbiome features and impaired antibody responses [7,8,9,10], but mechanistic data is lacking

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call